Zofran (Ondasetron): Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary Tags: Manual revert Visual edit |
||
| (20 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
[[Category:Drug]] | [[Category:Drug]] | ||
[[Category:Antiemetics]] | [[Category:Antiemetics]] | ||
[[Category:5-HT3]] | [[Category:5-HT3]] | ||
{{infobox drug | |||
| drug_name = zofranx | |||
| image = zofran.png | |||
| caption = zofran 4 mg tablet | |||
| type = antiemetic | |||
| used_for = prevention of nausea and vomiting | |||
| atc_code = A04AA01 | |||
| legal_status = prescription only | |||
| routes_of_administration = oral, intravenous, intramuscular | |||
| bioavailability = sss | |||
| protein_bound = 70-76% | |||
| metabolism = liver (CYP2D6, CYP3A4) | |||
| elimination_half-life = 3-6 hours | |||
| excretion = kidney (60%), feces (40%) | |||
}} | |||
'''Zofran''' ('''ondansetron''') is an [[antiemetic]] medication used to prevent [[nausea]] and [[vomiting]], particularly in the field of [[anesthesia]]. It is a selective [[5-HT3 receptor antagonist]], which works by blocking the action of [[serotonin]] in the brain and the gastrointestinal tract. | |||
==Route of administration== | |||
* Oral: Disintegrating tablets, film-coated tablets, and oral solution | |||
* Intravenous: Injection | |||
* Intramuscular: Injection | |||
*Intramuscular: Injection | |||
==Dose== | ==Dose== | ||
For anesthesia-related nausea and vomiting: | For anesthesia-related nausea and vomiting: | ||
* Adult: | * Adult: | ||
* Oral: 16 mg before anesthesia induction | * Oral: 16 mg before anesthesia induction | ||
* Intravenous: 4 mg before anesthesia induction or immediately before/during/after surgery | * Intravenous: 4 mg before anesthesia induction or immediately before/during/after surgery | ||
*Pediatric: | * Pediatric: | ||
* Oral: 4 mg for children aged 4-11 years, 30-60 minutes before surgery | * Oral: 4 mg for children aged 4-11 years, 30-60 minutes before surgery | ||
* Intravenous: 0.1 mg/kg (up to 4 mg) for children aged 1 month-12 years, immediately before/during/after surgery | * Intravenous: 0.1 mg/kg (up to 4 mg) for children aged 1 month-12 years, immediately before/during/after surgery | ||
==Half-life== | ==Half-life== | ||
*The elimination half-life of ondansetron is approximately 3-6 hours. | * The elimination half-life of ondansetron is approximately 3-6 hours. | ||
==Expected time to work== | ==Expected time to work== | ||
*Oral: Onset of action is approximately 30 minutes to 2 hours. | * Oral: Onset of action is approximately 30 minutes to 2 hours. | ||
*Intravenous: Onset of action is approximately 5-30 minutes. | * Intravenous: Onset of action is approximately 5-30 minutes. | ||
==Use in anesthesia== | ==Use in anesthesia== | ||
Zofran is commonly used in anesthesia to: | Zofran is commonly used in anesthesia to: | ||
*Prevent postoperative nausea and vomiting (PONV) | * Prevent postoperative nausea and vomiting (PONV) | ||
*Prevent nausea and vomiting induced by [[chemotherapy]] | * Prevent nausea and vomiting induced by [[chemotherapy]] | ||
*Prevent nausea and vomiting associated with [[radiation therapy]] | * Prevent nausea and vomiting associated with [[radiation therapy]] | ||
==Side effects== | ==Side effects== | ||
*Headache | * Headache | ||
*Fatigue | * Fatigue | ||
*Constipation | * Constipation | ||
*Diarrhea | * Diarrhea | ||
*Dizziness | * Dizziness | ||
== Contraindications == | ==Contraindications== | ||
*Hypersensitivity to ondansetron or any component of the formulation | * Hypersensitivity to ondansetron or any component of the formulation | ||
*Concomitant use with [[apomorphine]] | * Concomitant use with [[apomorphine]] | ||
*Patients with congenital long QT syndrome | * Patients with congenital long QT syndrome | ||
== Drug interactions== | ==Drug interactions== | ||
*[[Serotonin syndrome]] risk may increase when combined with other serotonergic agents (e.g., [[SSRIs]], [[SNRIs]], [[TCAs]], [[MAOIs]], [[triptans]]) | * [[Serotonin syndrome]] risk may increase when combined with other serotonergic agents (e.g., [[SSRIs]], [[SNRIs]], [[TCAs]], [[MAOIs]], [[triptans]]) | ||
==References== | ==References== | ||
| Line 55: | Line 67: | ||
==External links== | ==External links== | ||
*{{DrugBank|DB00904}} | * {{DrugBank|DB00904}} | ||
*{{RxList|Zofran}} | * {{RxList|Zofran}} | ||
* {{MedlinePlus|a601209}} | * {{MedlinePlus|a601209}} | ||
[[Category:5-HT3 antagonists]] | [[Category:5-HT3 antagonists]] | ||
Latest revision as of 22:39, 17 May 2023
Zofran (Ondasetron)
| drug name: | zofranx |
|---|---|
| image: | zofran.png |
| caption: | zofran 4 mg tablet |
| type: | antiemetic |
| routes of administration: | oral, intravenous, intramuscular |
| metabolism: | liver (CYP2D6, CYP3A4) |
| legal status: | prescription only |
| bioavailability: | sss |
| protein bound: | 70-76% |
| elimination half-life: | 3-6 hours |
| excretion: | kidney (60%), feces (40%) |
Zofran (ondansetron) is an antiemetic medication used to prevent nausea and vomiting, particularly in the field of anesthesia. It is a selective 5-HT3 receptor antagonist, which works by blocking the action of serotonin in the brain and the gastrointestinal tract.
Route of administration
- Oral: Disintegrating tablets, film-coated tablets, and oral solution
- Intravenous: Injection
- Intramuscular: Injection
Dose
For anesthesia-related nausea and vomiting:
- Adult:
* Oral: 16 mg before anesthesia induction * Intravenous: 4 mg before anesthesia induction or immediately before/during/after surgery
- Pediatric:
* Oral: 4 mg for children aged 4-11 years, 30-60 minutes before surgery * Intravenous: 0.1 mg/kg (up to 4 mg) for children aged 1 month-12 years, immediately before/during/after surgery
Half-life
- The elimination half-life of ondansetron is approximately 3-6 hours.
Expected time to work
- Oral: Onset of action is approximately 30 minutes to 2 hours.
- Intravenous: Onset of action is approximately 5-30 minutes.
Use in anesthesia
Zofran is commonly used in anesthesia to:
- Prevent postoperative nausea and vomiting (PONV)
- Prevent nausea and vomiting induced by chemotherapy
- Prevent nausea and vomiting associated with radiation therapy
Side effects
- Headache
- Fatigue
- Constipation
- Diarrhea
- Dizziness
Contraindications
- Hypersensitivity to ondansetron or any component of the formulation
- Concomitant use with apomorphine
- Patients with congenital long QT syndrome
Drug interactions
- Serotonin syndrome risk may increase when combined with other serotonergic agents (e.g., SSRIs, SNRIs, TCAs, MAOIs, triptans)
References